QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: mol.105.014795v1 68/6/1510    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hansen, K. B. Articles by Bräuner-Osborne, H. Search for Related Content PubMed PubMed Citation Articles by Hansen, K. B. Articles by Bräuner-Osborne, H.

Tweaking Agonist Efficacy at N-Methyl-D-aspartate Receptors by Site-Directed Mutagenesis

Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Copenhagen, Denmark (K.B.H., R.P.C., E.J.B., C.B., J.R.G., C.C., J.L.K., H.B.-O.); and Department of Molecular Neurobiology, H. Lundbeck A/S, Copenhagen, Denmark (K.B.H., C.B., J.E.)

The structural basis for partial agonism at N-methyl-D-aspartate (NMDA) receptors is currently unresolved. We have characterized several partial agonists at the NR1/NR2B receptor and investigated the mechanisms underlying their reduced efficacy by introducing mutations in the glutamate binding site. Key residues were selected for mutation based on ligand-protein docking studies using a homology model of NR2B-S1S2 built from the X-ray structure of NR1-S1S2 in complex with glycine. Wild-type and mutant forms of NR2B were coexpressed with NR1 in Xenopus laevis oocytes and characterized by two-electrode voltage-clamp electrophysiology. By combining mutagenesis of residues His486 or Val686 with activation by differently substituted partial agonists, we introduce varying degrees of steric clash between the ligand and the two binding domains S1 and S2. In cases where ligand-protein docking predicts increased steric clashes between agonists and the residues forming the S1-S2 interface, the agonists clearly show decreased relative efficacy. Furthermore, we demonstrate that the mutation S690A affects both potency and efficacy in an agonist-specific manner. The results indicate that essential residues in the ligand binding pocket of NR2B may adopt different conformations depending on the agonist bound. Together, these data indicate that agonist efficacy at the NR2B subunit can be controlled by the extent of steric clashes between the agonist and the ligand binding domains and by ligand-dependent arrangements of residues within the binding pocket.

Received for publication May 17, 2005.

Accepted for publication August 30, 2005.

Address correspondence to: Hans Bräuner-Osborne, Department of Medicinal Chemistry, Danish University of Pharmaceutical Sciences, Universitetsparken 2, DK-2100 Copenhagen, Denmark. E-mail: hbo{at}molpharm.net

This article has been cited by other articles:

				K. B. Hansen, P. Naur, N. L. Kurtkaya, A. S. Kristensen, M. Gajhede, J. S. Kastrup, and S. F. Traynelis Modulation of the Dimer Interface at Ionotropic Glutamate-Like Receptor {delta}2 by D-Serine and Extracellular Calcium J. Neurosci., January 28, 2009; 29(4): 907 - 917. [Abstract] [Full Text] [PDF]

				M. L. Blanke and A. M. J. VanDongen Constitutive Activation of the N-Methyl-D-aspartate Receptor via Cleft-spanning Disulfide Bonds J. Biol. Chem., August 1, 2008; 283(31): 21519 - 21529. [Abstract] [Full Text] [PDF]

				P. E. Chen, M. T. Geballe, E. Katz, K. Erreger, M. R. Livesey, K. K. O'Toole, P. Le, C. J. Lee, J. P. Snyder, S. F. Traynelis, et al. Modulation of glycine potency in rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes J. Physiol., January 1, 2008; 586(1): 227 - 245. [Abstract] [Full Text] [PDF]

				K. Erreger, M. T. Geballe, A. Kristensen, P. E. Chen, K. B. Hansen, C. J. Lee, H. Yuan, P. Le, P. N. Lyuboslavsky, N. Micale, et al. Subunit-Specific Agonist Activity at NR2A-, NR2B-, NR2C-, and NR2D-Containing N-Methyl-D-aspartate Glutamate Receptors Mol. Pharmacol., October 1, 2007; 72(4): 907 - 920. [Abstract] [Full Text] [PDF]

				P. Naur, K. B. Hansen, A. S. Kristensen, S. M. Dravid, D. S. Pickering, L. Olsen, B. Vestergaard, J. Egebjerg, M. Gajhede, S. F. Traynelis, et al. Ionotropic glutamate-like receptor {delta}2 binds D-serine and glycine PNAS, August 28, 2007; 104(35): 14116 - 14121. [Abstract] [Full Text] [PDF]

				D. J. A. Wyllie, A. R. Johnston, D. Lipscombe, and P. E. Chen Single-channel analysis of a point mutation of a conserved serine residue in the S2 ligand-binding domain of the NR2A NMDA receptor subunit J. Physiol., July 15, 2006; 574(2): 477 - 489. [Abstract] [Full Text] [PDF]